Table 1.
Baseline characteristics and multi system performance in study groups.
| Variable | RASa group | non-RAS group | P-value |
|---|---|---|---|
| (n = 21) | (n = 108) | ||
| General information | |||
| Age, mean(SD) | 63.9 ± 15.0 | 58.6 ± 13.5 | 0.146 |
| Male, n(%) | 16(80.0) | 91(86.7) | 0.436 |
| BMIb, mean(SD) (Kg/m2) | 27.2 ± 2.7 | 26.6 ± 4.2 | 0.617 |
| Heart rate, mean(SD) | 78.4 ± 12.0 | 78.8 ± 10.2 | 0.875 |
| Previous history | |||
| Smoking, n(%) | 7(33.3) | 32(29.6) | 0.735 |
| History of previous heart surgery, n(%) | 0(0) | 1(1.0) | 0.652 |
| Hypertension, n(%) | 16(76.2) | 69(63.9) | 0.277 |
| Coronary heart disease, n(%) | 1(4.8) | 6(5.6) | 0.883 |
| Diabetes, n(%) | 1(4.8) | 3(2.8) | 0.631 |
| Stroke, n(%) | 3(14.3) | 10(9.3) | 0.484 |
| Marfan's symdrome, n(%) | 0(0.0) | 1(0.9) | 0.658 |
| Renal artery condition | |||
| Normal, n(%) | 0(0.0) | 56(51.9) | |
| Hematoma compression, n(%) | 8(38.1) | 0(0.0) | |
| RAIc, n(%) | 13(61.9) | 52(48.1) | |
| Laboratory examination | |||
| EFd, mean(SD) (%) | 65.6 ± 5.3 | 63.3 ± 5.0 | 0.086 |
| Platelet, mean(SD) (109/L) | 205.7 ± 93.1 | 234.8 ± 96.5 | 0.217 |
| hemoglobin, mean(SD) (g/L) | 147.2 ± 15.6 | 149.1 ± 17.0 | 0.061 |
| sensitivity troponin I(SD)(μg/L) | 0.1 ± 0.3 | 0.1 ± 0.7 | 0.882 |
| ALTe, mean(SD)(U/L) | 28.1 ± 14.4 | 28.7 ± 26.8 | 0.921 |
| ASTf, mean(SD)(U/L) | 23.8 ± 8.0 | 28.1 ± 38.6 | 0.618 |
| D-dimer, median(IQR) (ng/ml) | 979(1542) | 844.5(1302.6) | 0.370 |
| WBCg, mean(SD) (109/L) | 11.7 ± 4.4 | 10.6 ± 4.8 | 0.331 |
a
RAS, Renal artery stenosis;
b
BMI, body mass index;
c
RAI, renal artery involvement;
d
EF, ejection fraction;
e
ALT, alanine aminotransferase;
f
AST, aspertate aminotransferase;
g
WBC, White blood cells; P < 0.05.